AngioGenex (CE) (AGGX)

AngioGenex Inc (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:AGGX

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
17/02/2022	18:26	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:AGGX	AngioGenex Inc (CE)
16/02/2022	21:41	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:AGGX	AngioGenex Inc (CE)
16/02/2022	18:50	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:AGGX	AngioGenex Inc (CE)
15/02/2022	21:42	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:AGGX	AngioGenex Inc (CE)
17/12/2021	20:41	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:AGGX	AngioGenex Inc (CE)
16/12/2021	11:02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AGGX	AngioGenex Inc (CE)
13/07/2020	20:06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AGGX	AngioGenex Inc (CE)
13/07/2020	11:01	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AGGX	AngioGenex Inc (CE)
11/02/2020	21:36	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AGGX	AngioGenex Inc (CE)
13/09/2019	18:41	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AGGX	AngioGenex Inc (CE)
14/08/2019	22:11	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AGGX	AngioGenex Inc (CE)
20/05/2019	22:28	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AGGX	AngioGenex Inc (CE)
15/05/2019	22:01	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:AGGX	AngioGenex Inc (CE)
01/04/2019	17:59	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:AGGX	AngioGenex Inc (CE)
28/03/2019	20:50	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:AGGX	AngioGenex Inc (CE)
04/02/2019	22:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:AGGX	AngioGenex Inc (CE)
13/11/2018	22:13	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AGGX	AngioGenex Inc (CE)
14/08/2018	19:59	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AGGX	AngioGenex Inc (CE)
06/07/2018	22:06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:AGGX	AngioGenex Inc (CE)
14/05/2018	22:30	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AGGX	AngioGenex Inc (CE)
02/04/2018	21:56	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:AGGX	AngioGenex Inc (CE)
23/01/2018	20:28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:AGGX	AngioGenex Inc (CE)
05/12/2017	20:10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:AGGX	AngioGenex Inc (CE)
01/12/2017	11:08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:AGGX	AngioGenex Inc (CE)
14/11/2017	11:08	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:AGGX	AngioGenex Inc (CE)
29/09/2017	22:33	Edgar (US Regulatory)	Amended Securities Registration (section 12(g)) (10-12g/a)	USOTC:AGGX	AngioGenex Inc (CE)
19/09/2017	20:53	Edgar (US Regulatory)	Amended Securities Registration (section 12(g)) (10-12g/a)	USOTC:AGGX	AngioGenex Inc (CE)
22/08/2017	22:00	Edgar (US Regulatory)	Securities Registration (section 12(g)) (10-12g)	USOTC:AGGX	AngioGenex Inc (CE)
22/08/2017	21:12	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:AGGX	AngioGenex Inc (CE)
28/06/2017	13:24	Edgar (US Regulatory)	Securities Registration (section 12(g)) (10-12g)	USOTC:AGGX	AngioGenex Inc (CE)